Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

April 14, 2020; 94 (15 Supplement) Tuesday, April 28

Duchenne Muscular Dystrophy (DMD) and Vitamin D deficiency (4461)

Tyler Tribble, Raj Razdan, Saila Upadhyayula, Karen Loechner, Sumit Verma
First published April 14, 2020,
Tyler Tribble
1Children’s Healthcare of Atlanta
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raj Razdan
1Children’s Healthcare of Atlanta
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Saila Upadhyayula
2Emory University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen Loechner
2Emory University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sumit Verma
1Children’s Healthcare of Atlanta
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Citation
Duchenne Muscular Dystrophy (DMD) and Vitamin D deficiency (4461)
Tyler Tribble, Raj Razdan, Saila Upadhyayula, Karen Loechner, Sumit Verma
Neurology Apr 2020, 94 (15 Supplement) 4461;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
0

Share

  • Article
  • Info & Disclosures
Loading

Abstract

Objective: 1. Study the influence of age, steroid use and ambulatory status on Vitamin D (vitD) levels in DMD boys. 2. Implementation of Bone Health Protocol (BHP) and its outcomes.

Background: DMD is an inherited neuromuscular condition that increases risk for bone health problems, including vitD deficiency. Limited data exists on how different variables affect this risk.

Design/Methods: Retrospective prospective study of DMD boys followed in the MDA clinic in a tertiary care Children’s Hospital from 2012–2019. Electronic medical records (EMR) for age, genotype, steroid use, ambulatory status and 25-HydroxyVitaminD (25OHD) levels reviewed and boys with two or more 25OHD levels recorded were included. In 2018, the BHP, an algorithm to diagnose and treat vitD deficiency, was implemented. Pre-and post-BHP vitD status was documented. Linear mixed effects models were used to assess vitD trajectories in different groups.

Results: Hundred and fourteen DMD boys, average age 15.1 years (range 4–25 years), 69.3% (n=79) deletion/duplications, 24.5% (n=28) point mutations, 6.1% (n=7) unrecorded genetics were included. 65% (n=74) received steroids, 63% (n=72) were non-ambulatory. Three hundred and two 25OHD values were available with an average of 26.12 ng/ml (range <13–83 ng/ml). Sub-group analysis showed statistically significant difference (p<0.05) with higher vitD levels in ambulatory boys age <12 years, with no difference in steroid versus steroid naive group. Prospectively, 52 subjects with vitD deficiency enrolled in BHP with 15 subjects completing 6 months follow-up, showing statistically significant improvement in 25OHD levels.

Conclusions: 25OHD levels are uniformly low in DMD boys. Linear mixed models showed a trend towards declining 25OHD levels with loss of ambulation and increasing age (>12 years), likely from multiple factors including poor compliance for vitD supplements and disease chronicity. Preliminary results from BHP implementation is showing promising improvement in 25OHD levels likely secondary to improved surveillance of vitD deficiency and uniform vitD deficiency treatment and supplementation.

Disclosure: Dr. Tribble has nothing to disclose. Dr. Razdan has nothing to disclose. Dr. Upadhyayula has nothing to disclose. Dr. Loechner has nothing to disclose. Dr. Verma has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with PTC Therapeutics.

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 96 (2)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2021 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise